Clinical Trial: Nasya in Allergic Rhinitis
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Double-blind, Randomized, Placebo-controlled, Crossover Clinical Investigation to Evaluate Safety and Efficacy of Nasya in Reducing Symptoms of Allergic Rhinitis When Appl
Brief Summary: The purpose of this study is to evaluate safety and efficacy of Nasya in reducing symptoms of persistent allergic rhinitis when applied before allergen challenge.
Detailed Summary:
Sponsor: InQpharm Group
Current Primary Outcome: Difference in Total Nasal Symptom Score [ Time Frame: 75 minutes ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- Difference in Total Nasal Symptom Score [ Time Frame: Up to 240 minutes ]
- Difference in Total Ocular Symptom Score [ Time Frame: Up to 240 minutes ]
Original Secondary Outcome: Same as current
Information By: InQpharm Group
Dates:
Date Received: December 27, 2011
Date Started: January 2012
Date Completion:
Last Updated: October 25, 2012
Last Verified: October 2012
